HomeCYAD • EBR
add
Celyad Oncology SA
Previous close
€0.33
Day range
€0.31 - €0.34
Year range
€0.30 - €1.28
Market cap
12.58M EUR
Avg Volume
13.63K
P/E ratio
-
Dividend yield
-
Primary exchange
EBR
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 29.00K | — |
Operating expense | 2.37M | -53.76% |
Net income | -2.35M | 82.48% |
Net profit margin | -8.12K | — |
Earnings per share | — | — |
EBITDA | -2.23M | 56.02% |
Effective tax rate | 1.32% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.00M | -43.72% |
Total assets | 16.28M | -17.42% |
Total liabilities | 9.98M | -35.20% |
Total equity | 6.30M | — |
Shares outstanding | 41.43M | — |
Price to book | 2.17 | — |
Return on assets | -36.11% | — |
Return on capital | -79.87% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -2.35M | 82.48% |
Cash from operations | -3.44M | 41.28% |
Cash from investing | -279.00K | -109.20% |
Cash from financing | 4.73M | 156.57% |
Net change in cash | 1.01M | 204.54% |
Free cash flow | -1.34M | 51.65% |
About
Founded
2004
Headquarters
Website
Employees
18
